2013-09-10 11:20:37 - Recently published research from MarketLine, "Biotechnology in Germany", is now available at Fast Market Research
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
* The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
* The German biotechnology market had total revenues of $7.7bn in 2012, representing a compound annual growth rate (CAGR) of 8.7% between 2008 and 2012.
* In 2012 many
companies in Europe were still preoccupied with matters of efficiency and raising funds in a difficult financing environment. These though conditions are however expected to ease going forward, which should facilitate good market growth.
* The performance of the market is forecast to decelerate, with an anticipated CAGR of 7.8% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $11.2bn by the end of 2017.
Full Report Details at
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Germany economy
Key Questions Answered
What was the size of the Germany biotechnology market by value in 2012?
What will be the size of the Germany biotechnology market in 2017?
What factors are affecting the strength of competition in the Germany biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Germany's biotechnology market?
Report Table of Contents:
TABLE OF CONTENTS
Market value forecast
Market value forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Related MarketLine research
LIST OF TABLES
Table 1: Germany biotechnology market value: $ billion, 2008-12
Table 2: Germany biotechnology market category segmentation: $ billion, 2012
Table 3: Germany biotechnology market geography segmentation: $ billion, 2012
Table 4: Germany biotechnology market value forecast: $ billion, 2012-17
Table 5: Boehringer Ingelheim GmbH: key facts
Table 6: Boehringer Ingelheim GmbH: key financials ($)
Table 7: Boehringer Ingelheim GmbH: key financials (EUR)
Table 8: Boehringer Ingelheim GmbH: key financial ratios
Table 9: Merck & Co., Inc.: key facts
Table 10: Merck & Co., Inc.: key financials ($)
Table 11: Merck & Co., Inc.: key financial ratios
Table 12: MorphoSys AG: key facts
Table 13: MorphoSys AG: key financials ($)
Table 14: MorphoSys AG: key financials (EUR)
Table 15: MorphoSys AG: key financial ratios
Table 16: Germany size of population (million), 2008-12
Table 17: Germany gdp (constant 2000 prices, $ billion), 2008-12
Table 18: Germany gdp (current prices, $ billion), 2008-12
Table 19: Germany inflation, 2008-12
Table 20: Germany consumer price index (absolute), 2008-12
Table 21: Germany exchange rate, 2008-12
LIST OF FIGURES
Figure 1: Germany biotechnology market value: $ billion, 2008-12
Figure 2: Germany biotechnology market category segmentation: % share, by value, 2012
Figure 3: Germany biotechnology market geography segmentation: % share, by value, 2012
Figure 4: Germany biotechnology market value forecast: $ billion, 2012-17
Figure 5: Forces driving competition in the biotechnology market in Germany, 2012
Figure 6: Drivers of buyer power in the biotechnology market in Germany, 2012
Figure 7: Drivers of supplier power in the biotechnology market in Germany, 2012
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2012
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2012
Figure 10: Drivers of degree of rivalry in the biotechnology market in Germany, 2012
Figure 11: Boehringer Ingelheim GmbH: revenues & profitability
Figure 12: Boehringer Ingelheim GmbH: assets & liabilities
Figure 13: Merck & Co., Inc.: revenues & profitability
Figure 14: Merck & Co., Inc.: assets & liabilities
Figure 15: MorphoSys AG: revenues & profitability
Figure 16: MorphoSys AG: assets & liabilities
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.